Literature DB >> 24008831

Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells--protective effect of cystamine and creatine.

Márcio Ribeiro1, Ana C Silva, Joana Rodrigues, Luana Naia, A Cristina Rego.   

Abstract

Huntington's disease (HD) is a polyglutamine-expansion disease associated to degeneration of striatal and cortical neurons. Previously, we showed that oxidative stress occurs in HD knock-in striatal cells, but little is known regarding cell antioxidant response against exogenous stimuli. Therefore, in the present study we analyzed cellular antioxidant profile following hydrogen peroxide (H2O2) and staurosporine (STS) exposure and tested the protective effect of cystamine and creatine in striatal cells expressing mutant huntingtin with 111 glutamines (STHdh (Q111/Q111); mutant cells) versus wild-type cells (STHdh (Q7/Q7)). Mutant cells displayed increased mitochondrial reactive oxygen species (ROS) and decreased NADPH oxidase and xanthine oxidase (XO) activities, reflecting lower superoxide cytosolic generation, along with increased superoxide dismutases (SODs) and components of glutathione redox cycle. Exposure to H2O2 and STS enhanced ROS in mutant cells and largely increased XO activity; STS further boosted the generation of mitochondrial ROS and caspase-3 activity. Both stimuli slightly increased SOD1 activity, without affecting SOD2 activity, and decreased glutathione reductase with a consequent rise in oxidized glutathione or glutathione disulfide in mutant cells, whereas H2O2 only increased glutathione peroxidase activity. Additionally, creatine and cystamine increased mutant cells viability and prevented ROS formation in HD cells subjected to H2O2 and STS. These results indicate that elevation of the antioxidant systems accompanies mitochondrial-driven ROS generation in mutant striatal cells and that exposure to noxious stimuli induces a higher susceptibility to oxidative stress by increasing XO activity and lowering the antioxidant response. Furthermore, creatine and cystamine are efficient in preventing H2O2- and STS-evoked ROS formation in HD striatal cells.

Entities:  

Keywords:  Huntington disease; glutathione cycle; mitochondria; mutant huntingtin; oxidative stress; reactive oxygen species; striatal cells; superoxide dismutases.

Mesh:

Substances:

Year:  2013        PMID: 24008831     DOI: 10.1093/toxsci/kft199

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  12 in total

Review 1.  Metabolic disturbances in diseases with neurological involvement.

Authors:  João M N Duarte; Patrícia F Schuck; Gary L Wenk; Gustavo C Ferreira
Journal:  Aging Dis       Date:  2013-11-30       Impact factor: 6.745

2.  Increased TRPC5 glutathionylation contributes to striatal neuron loss in Huntington's disease.

Authors:  Chansik Hong; Hyemyung Seo; Misun Kwak; Jeha Jeon; Jihoon Jang; Eui Man Jeong; Jongyun Myeong; Yu Jin Hwang; Kotdaji Ha; Min Jueng Kang; Kyu Pil Lee; Eugene C Yi; In-Gyu Kim; Ju-Hong Jeon; Hoon Ryu; Insuk So
Journal:  Brain       Date:  2015-06-30       Impact factor: 13.501

3.  Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease.

Authors:  Luana Naia; Teresa Cunha-Oliveira; Joana Rodrigues; Tatiana R Rosenstock; Ana Oliveira; Márcio Ribeiro; Catarina Carmo; Sofia I Oliveira-Sousa; Ana I Duarte; Michael R Hayden; A Cristina Rego
Journal:  J Neurosci       Date:  2017-01-25       Impact factor: 6.167

4.  Clonorchis sinensis ferritin heavy chain triggers free radicals and mediates inflammation signaling in human hepatic stellate cells.

Authors:  Qiang Mao; Zhizhi Xie; Xiaoyun Wang; Wenjun Chen; Mengyu Ren; Mei Shang; Huali Lei; Yanli Tian; Shan Li; Pei Liang; Tingjin Chen; Chi Liang; Jin Xu; Xuerong Li; Yan Huang; Xinbing Yu
Journal:  Parasitol Res       Date:  2014-11-22       Impact factor: 2.289

5.  Chemical interference with DSIF complex formation lowers synthesis of mutant huntingtin gene products and curtails mutant phenotypes.

Authors:  Ning Deng; Yun-Yun Wu; Yanan Feng; Wen-Chieh Hsieh; Jen-Shin Song; Yu-Shiuan Lin; Ya-Hsien Tseng; Wan-Jhu Liao; Yi-Fan Chu; Yu-Cheng Liu; En-Cheng Chang; Chia-Rung Liu; Sheh-Yi Sheu; Ming-Tsan Su; Hung-Chih Kuo; Stanley N Cohen; Tzu-Hao Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-01       Impact factor: 12.779

Review 6.  A mitochondrial basis for Huntington's disease: therapeutic prospects.

Authors:  J Chakraborty; U Rajamma; K P Mohanakumar
Journal:  Mol Cell Biochem       Date:  2013-12-29       Impact factor: 3.396

7.  Inhibition of Excessive Monoamine Oxidase A/B Activity Protects Against Stress-induced Neuronal Death in Huntington Disease.

Authors:  Jolene Ooi; Michael R Hayden; Mahmoud A Pouladi
Journal:  Mol Neurobiol       Date:  2014-11-15       Impact factor: 5.590

8.  Reduced cell size, chromosomal aberration and altered proliferation rates are characteristics and confounding factors in the STHdh cell model of Huntington disease.

Authors:  Elisabeth Singer; Carolin Walter; Jonasz J Weber; Ann-Christin Krahl; Ulrike A Mau-Holzmann; Nadine Rischert; Olaf Riess; Laura E Clemensson; Huu P Nguyen
Journal:  Sci Rep       Date:  2017-12-04       Impact factor: 4.379

9.  Cystamine preparations exhibit anticoagulant activity.

Authors:  Maria M Aleman; Lori A Holle; Katherine G Stember; Christa I Devette; Dougald M Monroe; Alisa S Wolberg
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

Review 10.  Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies.

Authors:  Giovanni Pagano; Annarita Aiello Talamanca; Giuseppe Castello; Mario D Cordero; Marco d'Ischia; Maria Nicola Gadaleta; Federico V Pallardó; Sandra Petrović; Luca Tiano; Adriana Zatterale
Journal:  Oxid Med Cell Longev       Date:  2014-05-04       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.